Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases
Open Access
- 1 January 1995
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (1) , 66-69
- https://doi.org/10.1128/aac.39.1.66
Abstract
Assessment of in vitro susceptibility testing of Helicobacter pylori is difficult because of the fastidious, slowly growing nature of this microorganism. The high rate of relapse observed clinically and a possible subpopulation of cells that are not actively replicating suggest the potential need for bactericidal therapy in order to eradicate H. pylori. We used modified time-kill kinetic methodology in order to evaluate the bactericidal activities of ampicillin and bismuth, alone and in combination, against three strains of H. pylori in both a stationary (slow) growth phase and a logarithmic (rapid) growth phase. We found that ampicillin produced a decrease in CFU per milliliter (2 to 4 log10 units) for three strains of H. pylori when tested in logarithmic growth phases but was less inhibitory (< 1-log10-unit decrease in CFU per milliliter) when tested in a stationary growth phase. In contrast, bismuth, when tested in a logarithmic growth phase, produced little inhibitory effect, as the CFU for all strains tested increased above the inoculum. However, when tested in a stationary growth phase, bismuth produced a decrease in CFU per milliliter of < 1 to > 3 log10 units). The activities of these two agents when combined mimicked the activity of the most active drug alone for that growth phase. We conclude that the clinical use of ampicillin combined with bismuth has been more effective than that of either agent used alone because ampicillin targets replicating cells, whereas bismuth targets cells that are not actively replicating.Keywords
This publication has 28 references indexed in Scilit:
- Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-upThe Lancet, 1994
- Helicobacter pylori: Its Role in DiseaseClinical Infectious Diseases, 1992
- Cure of duodenal ulcer associated with eradication of Helicobacter pyloriThe Lancet, 1990
- Pathogenesis of Peptic Ulcer and Implications for TherapyNew England Journal of Medicine, 1990
- Helicobacter pylori: Fact or Fiction?Scandinavian Journal of Gastroenterology, 1990
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988
- Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural studyJournal of Medical Microbiology, 1987
- The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridisJournal of Antimicrobial Chemotherapy, 1986
- Advances in the Understanding of the Mechanism of Cytoprotective Action by Colloidal Bismuth SubcitrateScandinavian Journal of Gastroenterology, 1986
- The ultrastructural localisation of de‐nol (colloidal tripotassium dicitrato‐bismuthate—TDB) in the upper gastrointestinal tract of man and rodents following oral and instrumental administrationThe Journal of Pathology, 1983